Sensus Healthcare Reports Record Second Quarter Financial Results
Revenue growth of 39% marks seventh consecutive quarter of double-digit year-over-year gains Conference call begins at 4:30 Eastern time today BOCA RATON, Fla., Aug. 3, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]
Sensus Healthcare Receives Regulatory Approval to Sell the SRT-100™ in China for the Treatment and Prevention of Keloids
BOCA RATON, Fla., July 26, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ has been cleared by the China Food and Drug Administration (CFDA) to treat and prevent keloids. China accounts for […]
Sensus Healthcare to Host Second Quarter 2017 Financial Results and Business Update Conference Call on August 3, 2017
BOCA RATON, Fla., July 25, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announces that management will hold a conference call beginning at 4:30 p.m. Eastern Time on Thursday, August 3, 2017 to discuss the financial […]
Sensus to Present at the 2017 Marcum MicroCap Conference
BOCA RATON, Fla., June 05, 2017 — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced Joe Sardano, the Company’s Chief Executive Officer, will present a corporate overview to investors at the 2017 Marcum MicroCap Conference on Thursday, […]
Sensus Healthcare Awarded 2017 Technology Leader of the Year for Disruptive Technology from Greater Miami Chamber of Commerce
BOCA RATON, Fla., May 24, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radiotherapy (SRT), has been awarded the 2017 Technology Leader of the Year for the Disruptive Technology category by The Greater Miami […]
Sensus Healthcare First Quarter Financial Results Feature Revenues up 43%
Sixth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 Eastern time today BOCA RATON, Fla., May 4, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the three months […]
Sensus Healthcare to Host First Quarter 2017 Financial Results and Business Update Conference Call on May 4, 2017
BOCA RATON, Fla., April 27, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announced today that management will hold a conference call beginning at 4:30 p.m. Eastern Time on Thursday, May 4, 2017 to discuss the […]
Sensus Healthcare issues letter to stockholders
BOCA RATON, Fla., April 24, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announces that Joe Sardano, chairman and chief executive officer issued today the following letter to stockholders: Dear Fellow Stockholder: Our first annual stockholders’ […]
Sensus Healthcare to Present at the 29th Annual ROTH Conference
BOCA RATON, Fla., March 7, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced that Joe Sardano, the Company’s chief executive officer, will present a corporate overview at the 29th Annual ROTH Conference on Wednesday, […]
Sensus Healthcare to Participate in 2017 South Beach Symposium on February 9 – 12 in Miami
— Joe Sardano, Sensus Healthcare CEO, to Participate in CEO Forum on February 11 — Sensus Healthcare Medical Advisory Board Members to Host SRT Workshops on February 9 BOCA RATON, Fla., Feb. 7, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin […]
